Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05125302 |
| Consolidated Lead Sponsor | AbbVie |
| Therapeutic Condition Cohort | Neurology, Psychiatry, and Pain |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 1,059 participants (ESTIMATED) |
| Registered Start Date | 2022-01-13 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Children's Hospital Los Angeles | Los Angeles, CA | Open Hospital Dossier -> |
| Velocity Clinical Research (Meridian) | Meridian, ID | Open Hospital Dossier -> |
| Children's Hospital of Philadelphia | Philadelphia, PA | Open Hospital Dossier -> |
| Huntsman Cancer Institute at University of Utah | Salt Lake City, UT | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for AbbVie across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.